Navigation Links
Polymedco Aligns with MedPrimex to Fight Colorectal Cancer in Mexico
Date:8/30/2012

CORTLANDT MANOR, N.Y., Aug. 30, 2012 /PRNewswire/ -- Polymedco Cancer Diagnostic Products, LLC ("Polymedco CDP") is pleased to announce that a distribution agreement was signed with MedPrimex, LLC ("MedPrimex").  The agreement provides distribution rights, for the Mexican market, to MedPrimex for Polymedco CDP fecal immunochemical test (FIT) product line for screening for colorectal cancer (CRC).  Colorectal cancer is among the leading causes of cancer death worldwide, but nearly half of people who die failed to get screened.

Early detection and treatment dramatically increase chances of survival. Screening is the most realistic approach to reducing new cases by finding non-cancerous colorectal polyps and removing them before they become cancerous. 

The OC automated FIT and manual OC Light® tests are quick and easy screening methods that measure human hemoglobin in the patient's stool.  The tests can be performed at home with little disruption to the patient's daily routine – requiring only one sample collection and no changes to diet or medication. The higher specificity of FIT means that there are less false positive results.

"Our goal is to introduce the benefits of getting an annual screening using a fecal immunochemical test (FIT) to people of Mexico," said Drew Cervasio, President of Polymedco. "Innovations in screening have significantly improved the detection of breast, prostate and cervical cancers so it is time to pay attention to the advances that can drive more patients to find colorectal cancer earlier."

"Through these screening tests, we are better able to accurately identify at-risk patients and send more of the right patients for further evaluation and colonoscopy," said Ana Maria Pedroza, CEO of MedPrimex. "We are proud to be a part of an effort that will ensure citizens of our country will have access to the best options for their healthcare needs."

About Polymedco Cancer Diagnostic Products, LLC

Polymedco Cancer Diagnostic Products, LLC is a leading manufacturer, marketer, and distributer in the clinical laboratory marketplace. Polymedco supplies clinical diagnostic test kits and devices that are specialized in cancer. We are a world leader in non-invasive colorectal cancer screening technology, providing the new standard of care with the OC -Auto® product line. Since 1980, Polymedco has evolved into a highly skilled and successful marketing, sales, and manufacturing organization.

Combined with an experienced team of field representatives and strong technical service personnel, Polymedco Cancer Diagnostic Products provides a high level of customer, technical and reimbursement support. To reach Polymedco Inc. via the worldwide web, log on to www.polymedco.com.

About MedPrimex, LLC

MedPrimex is a trusted Mexican company specialized in providing medical equipment, early detection systems, and disease prevention to preserve the health of the Mexican population. MedPrimex has strong ties with lead companies to deliver innovative health system solutions and advance medical technology. MedPrimex goal is preserving the health and quality of life of people.

MedPrimex has unparalleled service, expertise, product, and service offerings — delivering solutions that are innovative and practical. MedPrimex focuses on what matters most - improving people's lives. MedPrimex strives to work for the success of their customers by providing exceptional value and superior service to best satisfy their needs.

To reach MedPrimex via the worldwide web, log on to www.medprimex.com.


'/>"/>
SOURCE Polymedco Cancer Diagnostic Products, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmacists United for Truth and Transparency Marks One Year Anniversary of Fighting Abuses by Pharmacy Benefits Managers
2. Back to School Ideas: Vaccines for Kids Could Hurt Rather Than Help Fight Disease
3. Global pharmaceutical industry calls for broad-based cooperation to fight online sales of counterfeit medicines around the world
4. Makers Of Over-the-Counter Inhaler Leading Fight To Have Product Back On Market After Removal Due To Environmental Treaty
5. QIAGEN Achieves Personalized Healthcare Milestone with U.S. Approval of Companion Diagnostic for Colorectal Cancer
6. U.S. FDA Grants Priority Review to the New Drug Application for Bayers Regorafenib to Treat Patients with Metastatic Colorectal Cancer
7. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
8. Janssen Biotech Announces Global License and Development Agreement for Investigational Anti-Cancer Agent Daratumumab
9. Esperance Pharmaceuticals Announces Completion of Run-in Enrollment of Phase 2 Study of EP-100 Plus Paclitaxel in Advanced Ovarian Cancer
10. Breast Cancer Diagnostic and Drug Technologies: Global Markets
11. Human Vaccines & Immunotherapeutics Special Focus Highlights a Paradigm Shift in Cancer Vaccine Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical ... the "Company"), which develops, markets and sells medical devices ... , signed a strategic cooperation agreement with Hongyuan ... "Hongyuan Supply Chain") on June 20, 2016, to develop ... the strategic cooperation agreement, Dehaier will leverage Hongyuan Supply ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from PsychTests.com reveals that behind ...
(Date:6/24/2016)... PASADENA, CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. ... he would lash out at his family verbally and physically. , “When something upset him, ... table, he would use it. He would throw rocks at my other children and say ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
Breaking Medicine News(10 mins):